陈维洲, 董月丽, 汪长根, 丁光生. 丹参酮Ⅱ-A磺酸钠的药理研究J. 药学学报, 1979, 14(5): 277-283.
引用本文: 陈维洲, 董月丽, 汪长根, 丁光生. 丹参酮Ⅱ-A磺酸钠的药理研究J. 药学学报, 1979, 14(5): 277-283.
Chen Weizhou, Dong Yueli, Wang Changgen , Ting Guangsheng, . PHARMACOLOGICAL STUDIES OF SODIUM TANSHINONE Ⅱ-A SULFONATEJ. Acta Pharmaceutica Sinica, 1979, 14(5): 277-283.
Citation: Chen Weizhou, Dong Yueli, Wang Changgen , Ting Guangsheng, . PHARMACOLOGICAL STUDIES OF SODIUM TANSHINONE Ⅱ-A SULFONATEJ. Acta Pharmaceutica Sinica, 1979, 14(5): 277-283.

丹参酮Ⅱ-A磺酸钠的药理研究

PHARMACOLOGICAL STUDIES OF SODIUM TANSHINONE Ⅱ-A SULFONATE

  • 摘要: 丹参酮Ⅱ-A磺酸钠(丹参201)是丹参酮Ⅱ-A的新水溶性衍生物。临床试用中对冠心病心绞痛和胸闷的症状有一定疗效,并能改善缺血性心电图。本文进行了丹参201对小鼠缺氧、狗心脏血流动力作用和小鼠体内代谢的研究。腹腔注射200 mg/kg,可显著的延长小鼠在缺氧情况下的存活时间;氧耗速度较对照组稍减慢;其死亡时余存氧含量亦较对照组为低(P<0.05)。小鼠缺氧达到氧含量为6%时,心脏和脑组织中乳酸含量较正常组显著增加,而给丹参201后半小时再进行缺氧实验,组织中乳酸含量不增加,与正常组差异不显著。麻醉狗,一次静脉推注20 mg/kg,出现轻度血压升高,心输出量和左心室作功量稍有增加,心率和外周血管阻力的变化不显著。小鼠静注35S-丹参201后2分钟血中放射活性为75843 cpm/0.1 ml,90分钟已降至3785 cpm/0.1 ml。注后1小时,以肝、肺和肠中放射活性为高;肾、脾、心和胃次之。6和24小时均趋减少。肠内容物中的放射活性在不同时间内均占首位。胆囊中亦较多。24小时内尿和粪中排泄率分别为10.2%和32.0%;24~48小时内分别为4.5%和24.1%;48~72小时内分别为1.8%和19.6%。经非放射性和放射性薄层层析及放射自显影证明,由尿中排出的代谢物,一个为丹参201的原型,另一个为代谢产物,其基本骨架与原型相似,看来是增加了某些极性基团。

     

    Abstract: Sodium tanshinone Ⅱ-A sulfonate (danshen-201) is a new water-soluble derivative of tanshinone Ⅱ-A which was isolated from Salvia miltiorrhiza. In coronary patients danshen-201 ameliorated the anginal pain and the feeling of chest tightness, and improved the ischemic alterations in the electrocardiogram. This paper reports its effects on hypoxia in mice, hemodynamic studies in dogs and its metabolism in mice.In mice, an intraperitoneal injection of 200 mg/kg prolonged significantly the surviral time under hypoxia. The-rate of O2 consumption was retarded than in control mice. The amount of-residual O2 at death was less than in controls (p<0.05). When the ambient O2 content was lowered to 6%, the lactic acid concentrations in heart and brain of control mice increased markedly, whereas those of treated (danshen-201 was given 1/2 hr previously) mice did not increase.In anesthetized dogs an intravenous injection of 20 mg/kg brought about mild elevation of blood pressure, cardiac output and work of the left ventricle. The changes in heart rate and peripheral vascular resistance, were insignificant.35S-labeled danshen-201 was administered intravenously to mice. At 2 minutes the radioactivity in blood was found to be 75843 cpm/0.1 ml, lowered to 3785 cpm at 90 minutes. The average half-life was about 18 minutes. After 1 hr, the radioactivities were high in liver, lung and intestine, then came to heart and stomach, They all tended to decrease after 6 and 24 hrs. The radioactivities of the contents An the intestines ranked first for all times The amount was also considerable in gall-bladder. The excretion rates in urine and feces were 10.2% and 32%, resp., within 24 hrs; 4.5% and 24.1%, resp., on the 2nd day; and 1.8% and 19.6%, resp., on the 3rd day In the urine, danshen-201 per se as well as a metabolite were identified by both nonradioactive and radioactive thin-layer chromatography and autoradiography. This metabolite was found to have a basic-skeleton similar to the prototype of danshen-201 and seemed to have certain polar groups added.

     

/

返回文章
返回